• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地塞米松在神经黑色素驱动的帕金森病模型中的神经保护作用

Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson's Disease Model.

作者信息

Garcia-Gomara M, Juan-Palencia A, Alfaro M, Cuadrado-Tejedor M, Garcia-Osta A

机构信息

Gene Therapy for CNS Disorders Program, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.

IdiSNA (Navarra Institute for Health Research), Pamplona, Spain.

出版信息

J Neuroimmune Pharmacol. 2024 Dec 14;20(1):2. doi: 10.1007/s11481-024-10164-4.

DOI:10.1007/s11481-024-10164-4
PMID:39672994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11645310/
Abstract

Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra that primarily affects movement control. Neuroinflammation plays a pivotal role in driving the disease's progression. The persistent inflammatory state in the brain exacerbates neuronal damage, creating a cycle that perpetuates the neurodegenerative process. Glucocorticoids, such as dexamethasone, have potent anti-inflammatory properties and have been studied for their neuroprotective potential in different neurodegenerative diseases. However, their specific impact on PD remains unclear. This study aimed to evaluate the impact of dexamethasone on a neuromelanin (NM)-driven model of PD. We demonstrated that dexamethasone administration significantly improved motor function and preserved dopaminergic neuron compared to untreated controls in our study. These neuroprotective effects were mediated, at least in part, by suppressing reactive microglia and reducing the infiltration of peripheral immune cells into the brain. Our findings underscore the potential therapeutic benefits of dexamethasone in mitigating neuroinflammation and maintaining neuronal integrity in a NM-driven model of PD. These results advocate for further investigation into glucocorticoid-based therapies as adjunctive treatments for PD, particularly in scenarios where neuroinflammation contributes prominently to disease progression.

摘要

帕金森病(PD)的特征是黑质中多巴胺能神经元的渐进性丧失,主要影响运动控制。神经炎症在推动疾病进展中起关键作用。大脑中持续的炎症状态会加剧神经元损伤,形成一个使神经退行性过程持续下去的循环。糖皮质激素,如地塞米松,具有强大的抗炎特性,并已针对其在不同神经退行性疾病中的神经保护潜力进行了研究。然而,它们对PD的具体影响仍不清楚。本研究旨在评估地塞米松对神经黑色素(NM)驱动的PD模型的影响。我们证明,在我们的研究中,与未治疗的对照组相比,给予地塞米松显著改善了运动功能并保留了多巴胺能神经元。这些神经保护作用至少部分是通过抑制反应性小胶质细胞和减少外周免疫细胞向大脑的浸润来介导的。我们的研究结果强调了地塞米松在减轻NM驱动的PD模型中的神经炎症和维持神经元完整性方面的潜在治疗益处。这些结果主张进一步研究基于糖皮质激素的疗法作为PD的辅助治疗,特别是在神经炎症对疾病进展有显著贡献的情况下。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/46fd4f6d3eaf/11481_2024_10164_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/4058886d77a9/11481_2024_10164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/f3cda419a931/11481_2024_10164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/9edc8dd54064/11481_2024_10164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/b8ac8c15f3d9/11481_2024_10164_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/40d6f3c735df/11481_2024_10164_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/46fd4f6d3eaf/11481_2024_10164_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/4058886d77a9/11481_2024_10164_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/f3cda419a931/11481_2024_10164_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/9edc8dd54064/11481_2024_10164_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/b8ac8c15f3d9/11481_2024_10164_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/40d6f3c735df/11481_2024_10164_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a021/11645310/46fd4f6d3eaf/11481_2024_10164_Fig6_HTML.jpg

相似文献

1
Neuroprotective Effects of Dexamethasone in a Neuromelanin-Driven Parkinson's Disease Model.地塞米松在神经黑色素驱动的帕金森病模型中的神经保护作用
J Neuroimmune Pharmacol. 2024 Dec 14;20(1):2. doi: 10.1007/s11481-024-10164-4.
2
Alpha-Linolenic Acid for Mitigating Neuroinflammation and Dopaminergic Neuronal Loss in Parkinson's Disease: Insights From In Vivo and In Silico Studies.α-亚麻酸减轻帕金森病神经炎症和多巴胺能神经元损失:体内和计算机模拟研究的见解
Clin Exp Pharmacol Physiol. 2025 Jun;52(6):e70043. doi: 10.1111/1440-1681.70043.
3
GPR40 agonist ameliorates neurodegeneration and motor impairment by regulating NLRP3 inflammasome in Parkinson's disease animal models.GPR40 激动剂通过调节帕金森病动物模型中的 NLRP3 炎性小体改善神经退行性变和运动障碍。
Pharmacol Res. 2024 Nov;209:107432. doi: 10.1016/j.phrs.2024.107432. Epub 2024 Sep 21.
4
Infiltrating peripheral monocyte TREM-1 mediates dopaminergic neuron injury in substantia nigra of Parkinson's disease model mice.浸润性外周单核细胞TREM-1介导帕金森病模型小鼠黑质中多巴胺能神经元损伤。
Cell Death Dis. 2025 Jan 14;16(1):18. doi: 10.1038/s41419-025-07333-5.
5
Combination treatment with rapamycin and glucocorticoid protects the death of mesostriatal dopaminergic neurons in animal model of Parkinson's disease.
Pharmacol Biochem Behav. 2025 Mar;248:173966. doi: 10.1016/j.pbb.2025.173966. Epub 2025 Feb 3.
6
FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson's disease.在帕金森病的神经黑色素 - α-突触核蛋白小鼠模型中,FKBP51抑制可改善神经退行性变和运动功能障碍。
Mol Ther. 2025 Mar 5;33(3):895-916. doi: 10.1016/j.ymthe.2025.01.049. Epub 2025 Feb 3.
7
Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.鞣花酸苷可减轻帕金森病的神经炎症和细胞凋亡,并改变肠道微生物群和代谢物组成。
Phytomedicine. 2024 Feb;124:155309. doi: 10.1016/j.phymed.2023.155309. Epub 2023 Dec 20.
8
Wolfberry (Lycium barbarum) glycopeptide attenuates dopaminergic neurons loss by inhibiting lipid peroxidation in Parkinson's disease.枸杞糖肽通过抑制帕金森病中的脂质过氧化来减轻多巴胺能神经元损失。
Phytomedicine. 2025 Jan;136:156275. doi: 10.1016/j.phymed.2024.156275. Epub 2024 Nov 26.
9
Sofalcone attenuates neurodegeneration in MPTP-induced mouse model of Parkinson's disease by inhibiting oxidative stress and neuroinflammation.水飞蓟宾通过抑制氧化应激和神经炎症减轻 MPTP 诱导的帕金森病小鼠模型的神经退行性变。
Mol Biol Rep. 2024 Aug 14;51(1):908. doi: 10.1007/s11033-024-09852-4.
10
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.抑制JAK/STAT信号通路可预防α-突触核蛋白诱导的神经炎症和多巴胺能神经退行性变。
J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016.

引用本文的文献

1
Neuromelanin-induced cellular stress and neurotoxicity in the pathogenesis of Parkinson's disease.神经黑色素在帕金森病发病机制中诱导的细胞应激和神经毒性。
Apoptosis. 2025 Aug 7. doi: 10.1007/s10495-025-02156-3.

本文引用的文献

1
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.NLY01 在早期未经治疗的帕金森病中的安全性、耐受性和疗效:一项随机、双盲、安慰剂对照试验。
Lancet Neurol. 2024 Jan;23(1):37-45. doi: 10.1016/S1474-4422(23)00378-2.
2
In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson's disease.体内减少与年龄相关的神经黑色素积累可减轻帕金森病的特征。
Brain. 2023 Mar 1;146(3):1040-1052. doi: 10.1093/brain/awac445.
3
Microglia and astrocyte activation is region-dependent in the α-synuclein mouse model of Parkinson's disease.
在帕金森病的α-突触核蛋白小鼠模型中,小胶质细胞和星形胶质细胞的激活具有区域依赖性。
Glia. 2023 Mar;71(3):571-587. doi: 10.1002/glia.24295. Epub 2022 Nov 10.
4
Increased microglial activation in patients with Parkinson disease using [F]-DPA714 TSPO PET imaging.使用 [F]-DPA714 TSPO PET 成像技术观察到帕金森病患者的小胶质细胞激活增加。
Parkinsonism Relat Disord. 2021 Jan;82:29-36. doi: 10.1016/j.parkreldis.2020.11.011. Epub 2020 Nov 17.
5
ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease.小胶质细胞中活性氧的产生:理解神经退行性疾病中的氧化应激和炎症
Antioxidants (Basel). 2020 Aug 13;9(8):743. doi: 10.3390/antiox9080743.
6
Dexamethasone sodium phosphate attenuates lipopolysaccharide-induced neuroinflammation in microglia BV2 cells.地塞米松磷酸钠可减轻脂多糖诱导的小胶质细胞 BV2 细胞神经炎症。
Naunyn Schmiedebergs Arch Pharmacol. 2020 Sep;393(9):1761-1768. doi: 10.1007/s00210-019-01775-3. Epub 2020 Jan 8.
7
Midbrain microglia mediate a specific immunosuppressive response under inflammatory conditions.中脑小胶质细胞在炎症条件下介导一种特定的免疫抑制反应。
J Neuroinflammation. 2019 Nov 22;16(1):233. doi: 10.1186/s12974-019-1628-8.
8
Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis.脑酪氨酸酶过度表达提示帕金森病发病机制中与年龄相关的神经黑色素生成。
Nat Commun. 2019 Mar 7;10(1):973. doi: 10.1038/s41467-019-08858-y.
9
Determinants of dopaminergic neuron loss in Parkinson's disease.帕金森病中多巴胺能神经元丧失的决定因素。
FEBS J. 2018 Oct;285(19):3657-3668. doi: 10.1111/febs.14607. Epub 2018 Aug 14.
10
Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.小胶质细胞可能通过选择性消除苍白球谷氨酸能突触来补偿实验性帕金森病中多巴胺能神经元的丢失。
Glia. 2017 Nov;65(11):1833-1847. doi: 10.1002/glia.23199. Epub 2017 Aug 24.